HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lundin, L. Articles by Oberg, K. Search for Related Content PubMed PubMed Citation Articles by Lundin, L. Articles by Oberg, K.

The Journal of Thoracic and Cardiovascular Surgery, Vol 100, 552-561, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Surgical treatment of carcinoid heart disease

L Lundin, HE Hansson, J Landelius and K Oberg
Department of Cardiology, University Hospital, Uppsala, Sweden.

Right heart failure in patients with carcinoid heart disease is a serious prognostic sign. Consideration and adequate timing of valvular operations seem essential for the postoperative outcome. Without any relation to duration or progression of the metastasizing tumor disease, right heart failure developed and increased rapidly for a period of 12 to 17 months in four patients with classic carcinoid syndrome. Invasive hemodynamic and cardiac ultrasound investigations revealed severe carcinoid heart disease, and medical decompensation treatment gradually failed. Tricuspid and pulmonic valve replacement operations resulted in dramatic improvement in three of the patients, and these patients were still free of cardiac symptoms 10, 12, and 38 months postoperatively. One patient died 5 days postoperatively probably of septicemia. The preoperative and postoperative development of the cardiac disease is evaluated clinically, by cardiac ultrasound and plasma atrial natriuretic peptide concentrations, and related to the tumor disease. Surgical anatomy and operative technique are reported, and the beneficial value of prophylactic treatment of the effects of tumor- released vasoactive substances by a somatostatin analog is emphasized.

This article has been cited by other articles:

				T. N. Weingarten, M. D. Abel, H. M. Connolly, D. R. Schroeder, and H. V. Schaff Intraoperative Management of Patients with Carcinoid Heart Disease Having Valvular Surgery: A Review of One Hundred Consecutive Cases Anesth. Analg., November 1, 2007; 105(5): 1192 - 1199. [Abstract] [Full Text] [PDF]

				P. A. Robiolio, V. H. Rigolin, J. S. Wilson, J. K. Harrison, L. L. Sanders, T. M. Bashore, and J. M. Feldman Carcinoid Heart Disease : Correlation of High Serotonin Levels With Valvular Abnormalities Detected by Cardiac Catheterization and Echocardiography Circulation, August 15, 1995; 92(4): 790 - 795. [Abstract] [Full Text]